Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ)

On Thursday, March 14, 2024, Phase Holographic Imaging PHI AB (publ), company registration number 556542-7811 (the "Company") held an extraordinary general meeting. At the extraordinary general meeting, 3 674 shares were represented out of the 26 192 925 shares issued on the record date, corresponding to approximately 0,014 per cent of the total number of shares. Below is a summary of the resolutions passed.

Election of the board of directors

The extraordinary general meeting resolved that the board of directors shall consist of six (6) ordinary board members, without deputy board members. For the period until the next annual general meeting, the general meeting resolved to elect Ivan Jurkovic as ordinary board member.

Ivan Jurkovic, born in 1984, is an experienced financial business executive with experience from the pharmaceutical, beverage and IT industries. Jurkovic currently holds the position of Chief Financial Officer of Altium S.A. Within the scope of his assignment at Altium S.A., Jurkovic is responsible for the financial operations in nine countries and drives the development of financial strategy, risk management and sustainable growth.

For additional information, please contact:
Patrik Eschricht
E-mail: ir@phiab.com
Web: www.phiab.com – Live cell imaging & analysis

Phase Holographic Imaging (PHI) develops instrumentation and software for time-lapse cytometry. The products are used for long-term quantitative analysis of the dynamics of live cells, particularly significant in the research of cancer, as well as in the treatment of inflammatory and autoimmune diseases. The products are sold globally through the company's distributors. The company is based in Lund, Sweden, and in Boston, Massachusetts.